Welcome to our dedicated page for AUNA S.A. SEC filings (Ticker: AUNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Auna S.A. (NYSE: AUNA) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer. Auna files an annual report on Form 20-F and furnishes current information on Form 6-K, which together document its activities as a Latin American healthcare platform operating in Mexico, Peru, and Colombia. These filings include press releases on financial results, financing transactions, and operational milestones, as well as management’s discussion and analysis of financial condition and results of operations for specified periods.
Recent Form 6-K submissions reference quarterly financial results, including unaudited condensed consolidated interim financial statements, and discuss performance across Auna’s healthcare facilities and health plan portfolio. Other 6-K filings relate to proposed and completed offerings of senior secured notes, a significant debt refinancing, and cash tender offers and consent solicitations for outstanding notes. Through these documents, readers can follow how Auna describes its leverage ratios, debt maturity profile, and capital structure objectives.
Auna’s filings also incorporate disclosures on strategic initiatives. Examples include the expansion of its OncoMexico network through partnerships with medical institutions, a public–private partnership with EsSalud in Peru for the Torre Trecca outpatient treatment center, and a Memorandum of Understanding with Sojitz Corporation of America to explore healthcare opportunities in Latin America. These items appear in press releases that are furnished to the SEC as exhibits to Form 6-K reports.
On Stock Titan, users can review Auna’s 20-F and 6-K filings as they become available from EDGAR and use AI-powered summaries to interpret key points. This includes simplified explanations of annual and interim financial reporting, context around debt and note offerings, and highlights from operational and strategic disclosures, all based on the information Auna provides in its official filings.
Auna S.A. reported FY25 revenue of S/4,385 million, essentially flat year-over-year, while Adjusted EBITDA fell 8% to S/917 million with a 20.9% margin. Despite softer profitability, Adjusted Net Income more than doubled to S/336 million and free cash flow rose 35% versus 2024.
Peru led growth with 9% higher revenue and 14% Adjusted EBITDA growth, supported by strong oncology performance and improved medical loss ratios. Colombia grew revenue 5% but saw lower margins after 2024 one-offs. Mexico’s revenue declined 13% and Adjusted EBITDA 26% for the year, though oncology volumes and early 2026 trends show recovery signs.
The company completed a US$825 million refinancing, keeping net leverage at 3.6x Net Debt-to-Adjusted EBITDA and lifting cash to S/335 million. For 2026, Auna guides to roughly 12% FX-neutral growth in both revenue and Adjusted EBITDA, within a 10–14% range, and plans to hold capex near 4% of revenue.
Auna S.A. has executed an addendum to its Public-Private Partnership with EsSalud, formally authorizing construction of Torre Trecca in Lima, which is expected to become Peru’s largest outpatient facility. The 23-story center will have about 59,000 square meters, 145 consultation offices, and 43 treatment rooms.
Once completed, Torre Trecca is expected to expand EsSalud’s healthcare capacity in metropolitan Lima by roughly 20% and handle over three million patient visits per year. Operations are anticipated to start in mid-2028 under a concession running initially to 2046, with potential renewal to 2064.
The PPP structure uses a dedicated project vehicle and ring-fenced cash flows. After opening, EsSalud will make guaranteed minimum monthly payments through certificates that cover fixed and operating costs, creating a predictable revenue stream for Auna. Construction capex is largely reimbursed by EsSalud via progress certificates, limiting Auna’s upfront investment.
AUNA S.A. beneficial ownership disclosure: Reporting Persons state beneficial ownership of 655,538 Class A Ordinary Shares, representing
The filing identifies four Reporting Persons—Grupo Angeles Servicios de Salud, Grupo Vazol, Corpvaza and Mr. Olegario Vázquez Aldir—and explains the ownership chain by which Mr. Vázquez Aldir controls the entities that hold the shares. The cover responses list sole and shared voting and dispositive powers for the reported shares.
Schroder Investment Management Group has reported beneficial ownership of 1,098,509 shares of AUNA S.A., representing 3.7% of the outstanding class of SHS as of 12/31/2025. Schroder Investment Management Group and Schroder Investment Management Limited each report sole voting and sole dispositive power over these shares, with no shared voting or dispositive power.
The holders state that the securities were acquired and are held in the ordinary course of business and not for the purpose, or with the effect, of changing or influencing control of AUNA S.A. The filing confirms that their ownership represents 5 percent or less of the class.
AUNA S.A. received an amended Schedule 13G/A showing that Mexican investor group entities led by Mr. Olegario Vazquez Aldir report beneficial ownership of 2,225,281 Class A Ordinary Shares, or 7.39% of the class. This percentage is based on 30,095,388 Class A Ordinary Shares outstanding as of June 30, 2025, as disclosed in a prior Form 6-K/A.
The filing aggregates holdings of Grupo Angeles Servicios de Salud, Grupo Vazol, Corpvaza and Mr. Vazquez Aldir through a control chain in which GASS is the direct holder. The reporting persons certify the shares were not acquired to change or influence control of AUNA S.A.
Grupo Angeles Servicios de Salud and related parties report a 13.10% beneficial stake in AUNA S.A.’s Class A shares. The group reports beneficial ownership of 3,943,170 Class A Ordinary Shares, based on 30,095,388 shares outstanding as of June 30, 2025, as cited from a prior Form 6-K/A.
The reporting persons are Grupo Angeles Servicios de Salud, Grupo Vazol, Corpvaza and Mr. Olegario Vazquez Aldir, all organized or resident in Mexico. Mr. Vazquez Aldir directly controls Corpvaza, which controls Grupo Vazol, which is the parent of Grupo Angeles Servicios de Salud, the direct holder of the AUNA shares.
For the entities, voting and dispositive power over 3,943,170 shares is reported as shared, while Mr. Vazquez Aldir reports sole voting and dispositive power over the same amount. They certify the securities were not acquired to change or influence control of AUNA S.A.
Auna S.A. received a Schedule 13G reporting that a group of related Mexican entities and an individual investor together beneficially own 5,469,898 Class A Ordinary Shares, representing 18.18% of this share class. The direct holder is Grupo Angeles Servicios de Salud, S.A. de C.V., which is controlled through a chain of companies up to Mr. Olegario Vazquez Aldir.
The ownership percentage is calculated using 30,095,388 Class A Ordinary Shares outstanding as of June 30, 2025, as cited from a prior company report. The reporting group previously filed on Schedule 13D but now reports that it holds less than 20% of the outstanding Class A shares and certifies that the securities were not acquired and are not held for the purpose of changing or influencing control of Auna S.A.
Auna S.A. major shareholder group updated its ownership disclosure in an Amendment No. 5 to Schedule 13D. Grupo Angeles Servicios de Salud, Grupo Vazol, Corpvaza and Mr. Olegario Vazquez Aldir together may be deemed to beneficially own 5,869,747 Class A Ordinary Shares, representing about 19.50% of the company’s Class A stock, based on 30,095,388 shares outstanding as of June 30, 2025. From the date of Amendment No. 4 until January 15, 2026, Grupo Angeles Servicios de Salud sold 476,659 Class A Ordinary Shares for a total selling price of USD$2,282,493.00, and this amendment refreshes their reported stake and recent trading activity.
RWC Asset Management LLP, a United Kingdom-based investment adviser, reports beneficial ownership of 1,523,942 shares of AUNA, S.A., representing 5.07 % of this class of securities as of 12/31/2025. RWC holds sole power to vote and dispose of all of these shares, with no shared voting or dispositive power disclosed.
The position is held directly by RWC Asset Management LLP, which is classified as an investment adviser. The disclosure confirms that RWC is not part of a group, does not hold the stake on behalf of another person above the 5 % threshold, and that no group dissolution or subsidiary-level reporting is involved. The certification is signed by Fadi Freiha, Compliance Officer, dated 01/02/2026.
Fiera Capital (UK) Limited, an investment adviser based in London, reported beneficial ownership of 1,440,174 Class A Ordinary Shares of AUNA S.A., identified by CUSIP L0415A103. This position represents 4.8% of the Class A shares, putting its holdings below the 5% threshold that often signals a more significant stake.
The filing states that Fiera Capital (UK) Limited holds these shares as investment manager for various funds and that, as of the close of business on December 5, 2025, it owned less than 5% of AUNA S.A.’s Class A shares. The firm certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of AUNA S.A.